The association of an early hemoglobin response with alternative metrics to evaluate treatment efficacy of erythropoietic agents.

被引：0
|
作者：
Reed, SD
Radeva, JI
Daniel, D
Fastenau, JM
Williams, D
Schulman, KA
机构：
[1] Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Ortho Biotech LLC, Bridgewater, NJ USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234
引用
收藏
页码：71A / 71A
页数：1
相关论文
共 50 条
  • [1] Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia
    Reed, SD
    Radeva, JI
    Daniel, DB
    Fastenau, JM
    Williams, D
    Schulman, KA
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1527 - 1533
  • [2] TREATMENT WITH ERYTHROPOIETIC AGENTS OF ANAEMIA ASSOCIATED WITH MYELOFIBROSIS: EFFICACY AND PROGNOSTIC RESPONSE FACTORS
    Juan Carlos, Hernandez Boluda
    Juan Gonzalo, Correa
    Maria, Fortes
    Lopez Joaquin, Martinez
    Larran Alberto, Alvarez
    Maria Laura, Fox
    Gutierrez Valentin, Garcia
    Encinas Manuel, Perez
    Nataly, Ibarra
    Maria Isabel, Mata Vazquez
    Jose Maria, Raya
    Natalia, Estrada
    Anabel, Regadera
    Ana, Kerguelen
    Maria Antonia, Duran
    Manuel, Albors
    Francisco, Cervantes
    HAEMATOLOGICA, 2016, 101 : 84 - 84
  • [3] Early results from a choice based conjoint analysis assessing patient preferences for selected features of erythropoietic agents.
    Bolge, SC
    Fastenau, JM
    Howell, JB
    Piech, CT
    Donohue, JA
    BLOOD, 2004, 104 (11) : 412B - 412B
  • [4] Mycophenolate mofetil treatment in primary glomerular diseases without response to conventional immunosuppresive agents.
    Trinidad, PR
    Meza, LMM
    Diaz, OA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 800A - 800A
  • [5] Clinical trial protocol to evaluate the efficacy of cefixime in the treatment of early syphilis
    Shivani N. Mehta
    Chrysovalantis Stafylis
    David M. Tellalian
    Pamela L. Burian
    Cliff M. Okada
    Carl E. Millner
    Christopher M. Mejia
    Jeffrey D. Klausner
    Trials, 21
  • [6] Clinical trial protocol to evaluate the efficacy of cefixime in the treatment of early syphilis
    Mehta, Shivani N.
    Stafylis, Chrysovalantis
    Tellalian, David M.
    Burian, Pamela L.
    Okada, Cliff M.
    Millner, Carl E.
    Mejia, Christopher M.
    Klausner, Jeffrey D.
    TRIALS, 2020, 21 (01)
  • [7] Body composition and association with treatment toxicity in patients with advanced renal cell carcinoma receiving targeted agents.
    McCabe, Kelly
    Goh, Vicky
    Vinayan, Anup
    Petruckevitch, Ann
    Nathan, Paul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Development of a multiplex quantitative immunofluorescence assay to evaluate DNA damage repair deficient models in vitro and in vivo and the response to cytotoxic agents.
    Marrero, Allison M.
    Lawrence, Scott M.
    Wilsker, Deborah
    Balasubramanian, Priya
    Kinders, Robert J.
    Parchment, Ralph E.
    Tomaszewski, Joseph E.
    Doroshow, James H.
    CANCER RESEARCH, 2013, 73 (08)
  • [9] Augmentation of fetal hemoglobin (HbF) production in human erythroid cells by combined treatment with hemin and other HbF-inducing agents.
    Kollia, P
    Akel, S
    Zoi, K
    Likousi, S
    Papasotiriou, J
    Papapanagiotou, E
    Loukopoulos, D
    BLOOD, 2000, 96 (11) : 606A - +
  • [10] A new computerized memory test to evaluate early cognitive decline and treatment response
    Di Cesare, F.
    Novelli, M.
    Di Carlo, C.
    Fioravanti, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 450 - 450
12345